Jaana Nevalainen
Overview
Explore the profile of Jaana Nevalainen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
77
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kantomaa T, Vaarasmaki M, Gissler M, Ryynanen M, Nevalainen J
BMC Pregnancy Childbirth
. 2024 Sep;
24(1):580.
PMID: 39242998
Background: Maternal gestational diabetes (GDM), small (SGA) and large (LGA) for gestational age neonates are associated with increased morbidity in both mother and child. We studied how different levels of...
2.
Kantomaa T, Vaarasmaki M, Gissler M, Sairanen M, Nevalainen J
J Perinat Med
. 2023 Jan;
51(5):720-721.
PMID: 36607838
No abstract available.
3.
Kantomaa T, Vaarasmaki M, Gissler M, Sairanen M, Nevalainen J
J Perinat Med
. 2022 Sep;
51(4):500-509.
PMID: 36131518
Objectives: To evaluate different cut-off values of first trimester pregnancy associated plasma protein-A (PAPP-A) in screening for adverse pregnancy outcomes in a retrospective cohort study. Methods: During the study period...
4.
Alanen J, Appelblom H, Korpimaki T, Kouru H, Sairanen M, Gissler M, et al.
Arch Gynecol Obstet
. 2020 Jul;
302(4):853-860.
PMID: 32653948
Purpose: To evaluate the performance of first trimester maternal serum glycosylated (Sambucus nigra lectin-reactive) fibronectin in prediction of gestational diabetes mellitus (GDM). Methods: In this case-control study, first trimester maternal...
5.
West S, Ollila M, Franks S, Piltonen T, Jokelainen J, Nevalainen J, et al.
Acta Obstet Gynecol Scand
. 2020 Apr;
99(10):1311-1319.
PMID: 32333801
Introduction: The aim of the study was to determine the association of body mass index (BMI), self-reported symptoms or diagnosis of polycystic ovary syndrome (PCOS), and hyperandrogenemia with the occurrence...
6.
Nevalainen J, Ignatius J, Savolainen E, Ryynanen M, Jarvenpaa J
Eur J Obstet Gynecol Reprod Biol
. 2018 Sep;
230:32-35.
PMID: 30243226
Objective: Maternal thrombophilia is a risk factor for adverse pregnancy outcomes. The aim of this study was to elucidate the controversial role of fetal and paternal thrombophilia in the development...
7.
Alanen J, Korpimaki T, Kouru H, Sairanen M, Leskinen M, Gissler M, et al.
J Matern Fetal Neonatal Med
. 2018 Apr;
32(19):3272-3277.
PMID: 29683008
To evaluate the performance of first trimester biochemical markers, pregnancy-associated plasma protein-A (PAPP-A), free beta human chorionic gonadotropin (fβ-hCG), and nuchal translucency (NT) in detection of severe congenital heart defects...
8.
Nevalainen J, Aukee P
Duodecim
. 2017 Dec;
132(21):2011-3.
PMID: 29190053
Ectopic pregnancy after hysterectomy is a rare but potentially life-threatening condition. If ovaries are present, ectopic pregnancy should be ruled out in women with acute abdominal pain and history of...
9.
Alanen J, Leskinen M, Sairanen M, Korpimaki T, Kouru H, Gissler M, et al.
J Matern Fetal Neonatal Med
. 2017 Nov;
32(9):1454-1460.
PMID: 29157037
Objective: To evaluate the performance of first-trimester measurement of fetal nuchal translucency (NT) in the detection of severe congenital heart defects (CHDs). Methods: During the study period of 1 January...
10.
Nevalainen J, Korpimaki T, Kouru H, Sairanen M, Ryynanen M
Metabolism
. 2017 Oct;
75:6-15.
PMID: 28964327
Objective: To develop a predictive risk model for early-onset pre-eclampsia (EO-PE) using maternal characteristics, combined screening markers, previously reported biomarkers for PE and mean arterial pressure (MAP). Methods: This retrospective...